Colloid adverse effects

Consequently, when selecting and blending the various raw materials used in all-polymer/all-organic formulations, the questions of thermal and hydrolytic stability and ability to transport or otherwise control colloidal iron oxides (in addition to possible adverse effects such as copper corrosion) become increasingly important at higher boiler temperatures and pressures. 

Generally, the major adverse effects associated with colloids are fluid overload, dilutional coagulopathy, and anaphy-lactoid/anaphylactic reactions.24,32 Although derived from pooled human plasma, there is no risk of disease transmission from commercially available albumin or PPF products since they are heated and sterilized by ultrafiltration prior to distribution.24 Because of direct effects on the coagulation system with the hydroxyethyl starch and dextran products, they should be used cautiously in hemorrhagic shock patients. This is another reason why crystalloids maybe preferred in hemorrhagic shock. Furthermore, hetastarch can result in an increase in amylase not associated with pancreatitis. As such, the adverse-effect profiles of the various fluid types should also be considered when selecting a resuscitation fluid. 

Microbial activity can also be stimulated by mineral colloids through their ability to sorb metabolites that would otherwise have an adverse effect on microbial growth (Filip et al. 1972 Filip and Hattori 1984) This may be due to the toxicity of metabolites, and their feed back repression and, encouraging competitors. Predictably, montmorillonite (CEC —100 cmol kg-1 and specific surface of 800 m g 1) is more effective than kaolinite and finely ground quarts. Other substances, such as antibiotics and pesticides that are toxic to some microorganisms, can also be adsorbed by the surfaces of mineral colloids (Theng and Orchard 1995 Dec et al. 2002). 

Adverse effects of colloids are generally extensions of their pharmacologic activity (e.g., fluid overload, dilutional coagulopathy). Albumin and dex-tran may be associated with anaphylactoid reactions or anaphylaxis. Bleeding may occur in certain patients receiving hetastarch and dextran. 

Occasionally, the phosphate slime is difficult to settle in the lagoons because of its true colloidal nature, and the use of calcium sulfate or other electrolytes can promote coagulation, agglomeration, and settling of the particles. Usually an addition of calcium sulfate is unnecessary, because it is present in the wastewater from the sand-flotation process. Generally, it has been shown [33] that the clear effluent from the phosphate mining and beneficiation operation is not deleterious to fish life, but the occurrence of a dam break may result in adverse effects [19]. 

The number of studies on the health effects of fullerenes and carbon nanotubes is rapidly increasing. However, the data on their toxicity are often mutually contradictory. For example, the researchers from universities of Rice and Georgia (USA) found that in aqueous fullerene solutions colloidal nano-C particles were formed, which even at low concentration (approximately 2 molecules of fullerene per 108 molecules of water) negatively influence the liver and skin cells [17-19]. The toxicity of this nano-C aqueous dispersion was comparable to that of dioxins. In another smdy, however, it was shown that fullerene had no adverse effects and, on the contrary, had anti-oxidant activity [20]. Solutions of prepared by a variety of methods up to 200 mg/mL were not cytotoxic to a number of cell types [21]. The contradiction between the data of different authors could be explained by different nano-C particles composition and dispersion used in research. 

Aspirin, paracetamol, and hydrocortisone are used to control febrile reactions of amphotericin. Patients with a history of adverse effects with amphotericin should be prophylactically treated with antipyretics and hydrocortisone. Antiemetics and pethidine also are used for the treatment of adverse effects of amphotericin. With sodium supplements and hydration therapy, damage to the kidney can be reduced. If conventional amphotericin is not well tolerated by the patient, colloidal carriers can be used as alternative options. Administration of amphotericin with a nephrotoxic drug, such as cyclosporin, may further increase toxicity. Diuretics and anticancer drugs should be avoided with amphotericin. 

Wastewater treatment systems can be classified, in addition to pretreatment, as preliminary, primary, secondary, and tertiary (advanced) treatments. Pretreatment of industrial wastewater is required to prevent adverse effects on the municipal wastewater treatment plants. Preliminary treatment is considered as any physical or chemical process that precedes primary treatment. The preliminary treatment processes may consist of influent screening and grit removal. Its function is mainly to protect subsequent treatment units and to minimize operational problems. Primary treatment is defined as the physical or chemical treatment for the removal of settleable and floatable materials. The screened, degritted raw wastewater from preliminary treatment flows to the primary clarification tanks, which are part of the primary treatment facilities. Secondary wastewater treatment is the process that uses biological and chemical treatment to accomplish substantial removal of dissolved organics and colloidal materials. The secondary treatment facilities may be comprised of biological reactor and secondary clarification basins. Tertiary (advanced) wastewater treatment is used to achieve pollutant reductions by methods other than those used in primary and secondary treatments. The objective of tertiary wastewater treatment is to improve the overall removal of suspended solids, organic matter, dissolved solids, toxic substances, and nutrients. 

The colloids, in particular albumin, are expensive solutions. Therefore, it is difficult to justify the additional cost of colloidal products unless the benefit-to-risk ratio is substantially greater than that associated with inexpensive crystalloid solutions. This does not appear to be the case based on randomized, controlled studies and meta-analyses comparing colloid and crystalloid solutions for acute circulatory insufficiency. Because other colloids, such as hetastarch, almost always have been compared with albumin and not with crystalloid solutions in published clinical studies (with no clinically important differences being found), there is no reason to suspect that these other colloids have any unique advantages as volume expanders. Adverse effects associated with colloids appear to be uncommon and generally are extensions of their pharmacologic activity (Table 24—4), but this is also true of crystalloids. The benefit-to-risk ratio appears to be similar for colloids and crystalloids thus, based on cost, crystalloids are preferred for initial treatment of circulatory insufficiency. 

TABLE 24—4. Adverse Effects of Plasma Expanders Colloids... 

The use of Cremophore EL in the microemulsions is avoided nowadays due to several adverse effects such as anaphylactic shocks and histamine release [20 ]. The other important consideration is the concentration of surfactants and co-surfactants which should be minimal and preferably not exceed 20%. Furthermore, it is necessary to ensure that the microemulsion structure is preserved in the presence of the tonicity adjusting solutions such as 0.9% saline solution and preservatives. The parenteral microemulsions should also be able to withstand tests such as freeze-thaw cycling which ensure their physical stability. It has been shown that the colloidal carriers based on Solutol HS 15 can withstand freeze-thaw cycling very efficiently whereas lecithins can offer stability to autoclaving [ 112 ]. Cosurfactants such as benzyl alcohol cannot be used for intravenous applications but can be used for the small volume parenteral products up to the concentration of 1% w/v. Ethanol at concentrations above 10% usually results in the pain on injection. Co-surfactants such as glycofurol are reported to acceptable for parenteral products but there are no products based on glycofurol available for the human use. The pyrrolidone derivatives are reported to be acceptable for veterinary applications. 

Nanoparticles are solid colloidal polymeric carriers (less than 1 pm in size) that have received much attention over the recent years due to their ability to control dmg release and distribution and due to their biodegradabdity [62]. Furthermore, these systems have proven their potential to administer peptides or other drugs either by intravenous or oral routes, increasing their bioavailability and protection of the dmg against degradation, and reducing the associated adverse effects [63,64]. 

On the basis of the PAH rejections of over 90%, the permeate would be expected to be acceptable for discharge to POTWs (Publically Owned Treatment Works) with little or no polishing. Other pollutants found in ccaitaminated waters at wood treatment facilities (e.g., polychlorinated dioxins and furans) also are concentrated in the reject stream. Other constituents commonly encountered at such sites including colloidal oils and suspended solids are also extensively removed by the membrane process. Removal efficiencies for oil and grease were 93%. Suspended solids were removed to nrai-detectable levels. These materials did not appear to have an adverse effect on the filtration process. 

---